OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
25
Results
Show all
Save search
Copy query
Show results for
Unknown
(24)
Proteomics
(1)
Organisms
Plethodon shermani
(1)
Desmognathus ocoee
(1)
Chloris chloris chloris
(1)
Monascus purpureus
(1)
Cinclus cinclus
(1)
JC polyomavirus
(1)
Phylloscopus collybita
(1)
NEWT:5145
(1)
Acrocephalus palustris
(1)
Prunus dulcis
(1)
Mizuhopecten yessoensis
(1)
Squalus acanthias
(1)
wood decay metagenome
(1)
Hypotermes
(1)
Aspergillus flavus var. flavus
(1)
Pasteurella multocida
(1)
Babesia canis
(1)
Monilinia laxa
(1)
Naegleria sp. NGES2
(1)
Human alphaherpesvirus 1 strain F
(1)
Populus deltoides
(1)
Plasmodium coatneyi
(1)
Mycobacterium avium subsp. avium ATCC 25291
(1)
Babesia canis canis
(1)
Plasmodium cynomolgi strain B
(1)
Herpesvirales
(1)
Ceratocystis manginecans
(1)
Bacteroides ovatus str. 3725 D1 iv
(1)
Bacteroides faecis MAJ27
(1)
Phocaeicola massiliensis B84634 = Timone 84634 = DSM 17679 = JCM 13223
(1)
Repository
pride
(1)
Tissue
Macrophage
(1)
Technology Type
Mass Spectrometry
(1)
Shotgun proteomics
(1)
Publication Date
2022
(1)
Release Date
2021
(7)
2022
(5)
2018
(4)
2024
(2)
2023
(2)
2025
(1)
2020
(1)
2016
(1)
2013
(1)
Lab affiliation
Trinity College Dublin, Ireland
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Explorining the effect of LPS treatment on mouse macrophages
Proteomic assessment of mouse macrophages treated with LPS for 24 h.
ORGANISM(S):
Mus musculus (Mouse)
2022-02-15
|
PXD029155
|
Pride
Mouse macrophage lps
Cite
CSHP Professional Practice Conference 2019: Poster Abstracts
Not available
S-EPMC6391241
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants.
Not available
S-EPMC3837047
|
biostudies-literature
Cite
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10831058
|
biostudies-literature
Cite
Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage.
Not available
S-EPMC5345109
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607
|
biostudies-literature
Cite
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
